These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12444194)

  • 21. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
    Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
    Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma and hepatitis B e antigen.
    Kane LS
    J Insur Med; 2003; 35(1):57-8. PubMed ID: 14694826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.
    Sherman M
    Cleve Clin J Med; 2009 May; 76 Suppl 3():S6-9. PubMed ID: 19465708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations.
    Liu CJ; Kao JH
    J Gastroenterol Hepatol; 2008 Mar; 23(3):347-50. PubMed ID: 18318819
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocellular carcinoma and hepatitis B virus.
    Chan HL; Sung JJ
    Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection.
    Zhao H; Miao R
    Hepatology; 2009 Aug; 50(2):658; author reply 658-9. PubMed ID: 19585650
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
    Dai CY; Chuang WL; Huang JF; Yu ML
    Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
    [No Abstract]   [Full Text] [Related]  

  • 30. Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study.
    Nakayoshi T; Maeshiro T; Nakayoshi T; Nakasone H; Sakugawa H; Kinjo F; Orito E; Mizokami M
    J Med Virol; 2003 Jul; 70(3):350-4. PubMed ID: 12766996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fibrolamellar hepatocellular carcinoma in a patient with chronic viral B hepatitis].
    Da Ines D; Lannareix V; Petitcolin V; Bailly A; Charpy C; Abergel A; Chipponi J; Garcier JM
    Gastroenterol Clin Biol; 2009 May; 33(5):382-6. PubMed ID: 19361940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the natural history of chronic hepatitis B].
    Wu G; Zhou W; Zhao Y; Guo S; Wang Z; Zou S; Zhang Q; Ren H; Huang A; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):46-8. PubMed ID: 11856503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.
    Hoshida Y
    J Hepatol; 2009 Nov; 51(5):842-4. PubMed ID: 19748698
    [No Abstract]   [Full Text] [Related]  

  • 35. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the relationship between genotype D of hepatitis B virus and hepatocellular carcinoma].
    Xu ZJ; Zhang JL; Yang H; Zhang QH; Chen XL
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):385-6. PubMed ID: 15918981
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of hepatitis B and transplantation in the hepatitis B patient.
    Garcia G; Petrovic LM; Vierling JM
    Semin Liver Dis; 2000; 20 Suppl 1():3-6. PubMed ID: 10895437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma.
    Branda M; Wands JR
    Hepatology; 2006 May; 43(5):891-902. PubMed ID: 16628664
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.
    Colin JF; Cazals-Hatem D; Loriot MA; Martinot-Peignoux M; Pham BN; Auperin A; Degott C; Benhamou JP; Erlinger S; Valla D; Marcellin P
    Hepatology; 1999 Apr; 29(4):1306-10. PubMed ID: 10094979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.